This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This article is copyrighted strictly for Electronic Health Reporter. UC Riverside’s Wet Lab Incubator has opened its doors to biotech entrepreneurs throughout the Inland Empire. The article UC Riverside’s Wet Lab Incubator Open To Biotech Entrepreneurs appeared first on electronichealthreporter.com.
The following is a guest article by Steve Lazer, Global Healthcare & LifeSciences CTO at Dell Technologies. One rapidly advancing trend in healthcare and lifesciences is the shift from inefficient, expensive physical models to digital models tested in the virtual world.
The following is a guest article by Steve Lazer, Global Healthcare & LifeSciences CTO at Dell Technologies. The primary use cases for cognitive AI in biotech include accelerating data analysis, automating document management, improving collaboration, and reducing risk of human error.
With long-term backing from AstraZeneca and strategic collaborations with Parexel and Fortrea, Evinova offers globally-scaled digital products and services to the lifesciences and healthcare sector. 7 Many groups, including marginalised racial and ethnic groups, women, and other populations are underrepresented in clinical trials.
Dr. Fendrick was part of a team that wrote one of the first research articles on the effects of increasing patient cost sharing on health disparities — published in 2008 in the Journal of General Internal Medicine. ” Out of the mouths of Mom’s, right?!
This article is copyrighted strictly for Electronic Health Reporter. a lifescience company specializing in the development of blood tests for cancer and autoimmune diseases, has secured an initial closing of $3.1million on a Series C financing round. The article Inanovate Inc. Illegal copying is prohibited. Secures $3.1
The Connected Health Conference also promises an emphasis on the LifeSciences/BioTech and Digital Health, with sessions like the Fireside Chat on Pharma and Digital Health and Transforming the LifeSciences through Digital Health. Can't meet you there? No problem! Carrie Nixon. Carrie Nixon, Esq.
QuantHealth proudly supports several large pharma companies, numerous biotechs, as well as CROs, and other industry partners. According to a recent Deloitte article , ROI on pharma R&D has steadily declined, reaching 1.2 Contacts Isabella Morreale quanthealth@solcomms.co
This article will be a roundup of interesting stories, product announcements, partnerships, research studies, company launches, and more from the annual conference. RedHealthy Communications : PR and marketing for biotech, lifesciences, and digital health. Additionally, ambient sensor vendor care.ai
This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Engagement platform Twilio released a customer data platform for health and lifesciences. The Biotech Breakthrough Awards Program announced its 2022 award winners.
The New England Journal of Medicine published an essay on June 4, 2020, titled, Specialty Drugs–A Distinctly American Phenomenon (my apologies–the article is behind the NEJM paywall). The phrase “specialty drugs” originated in the 1970s in the advent of injectable and infusion therapies.
Beth writes that, “a whopping two-thirds of Americans now offer a thumbs-up on pharma” as the title of her article, calling out the 30-point gain from 32% in January 2020 to 62% in February 2021. Right now they’re very science- and research-forward versus very business-forward.”. Why was this the case?
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content